Alpa Laboratories Limited (BOM:532878)

Alpa Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	28.39	22.22	17.1	88.14	15.75
Short-Term Investments	-	1,350	-	-	-	-
Trading Asset Securities	-	-	1,105	911.43	720.28	686.99
Cash & Short-Term Investments	1,379	1,379	1,127	928.54	808.42	702.74
Cash Growth	22.35%	22.31%	21.39%	14.86%	15.04%	65.38%
Accounts Receivable	-	408.31	468.26	411.52	467.33	380.35
Other Receivables	-	28.94	46.34	21.88	1.52	46.71
Receivables	-	442.55	519.97	439.11	474.47	432.43
Inventory	-	133.33	176.4	136.65	126.41	154.64
Prepaid Expenses	-	-	2.57	3.12	2.53	2.55
Other Current Assets	-	154.37	98.75	102.42	79.45	87.75
Total Current Assets	-	2,109	1,925	1,610	1,491	1,380
Property, Plant & Equipment	-	201.2	206.04	114.13	69.59	92.16
Long-Term Investments	-	66.21	87.71	82.71	77.66	74.7
Other Intangible Assets	-	0.36	0.48	0.6	0.83	1.04
Other Long-Term Assets	-	44.71	7.16	16.45	33.33	4.37
Total Assets	-	2,421	2,226	1,824	1,673	1,552

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	177.91	186.94	117.77	150.58	149.23
Accrued Expenses	-	-	42.21	22.16	12.89	12.17
Short-Term Debt	-	25.08	0.34	44.59	-	23.44
Current Portion of Long-Term Debt	-	-	-	7.88	15.27	13.79
Current Unearned Revenue	-	-	-	-	-	59.96
Other Current Liabilities	-	322.29	237.51	88.27	117.59	29.54
Total Current Liabilities	-	525.27	467	280.67	296.33	313.83
Long-Term Debt	-	-	-	-	7.77	21.25
Long-Term Deferred Tax Liabilities	-	33.36	44.93	23.96	22.83	-
Other Long-Term Liabilities	-	-	-	-0	-0	-
Total Liabilities	-	558.64	511.94	304.62	326.92	335.08

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	210.41	210.41	210.41	210.41	210.41
Additional Paid-In Capital	-	-	549.61	549.61	549.61	549.61
Retained Earnings	-	-	954.33	759.09	585.77	457.3
Comprehensive Income & Other	-	1,652	-	-	-	-
Shareholders' Equity	1,863	1,863	1,714	1,519	1,346	1,217
Total Liabilities & Equity	-	2,421	2,226	1,824	1,673	1,552

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	25.08	25.08	0.34	52.47	23.04	58.47
Net Cash (Debt)	1,354	1,354	1,127	876.07	785.38	644.27
Net Cash Growth	20.13%	20.13%	28.63%	11.55%	21.90%	52.31%
Net Cash Per Share	67.65	-	53.56	41.64	37.33	30.62
Filing Date Shares Outstanding	20.01	-	21.04	21.04	21.04	21.04
Total Common Shares Outstanding	20.01	-	21.04	21.04	21.04	21.04
Working Capital	-	1,584	1,458	1,329	1,195	1,066
Book Value Per Share	-	-	81.48	72.20	63.96	57.86
Tangible Book Value	1,862	1,862	1,714	1,518	1,345	1,216
Tangible Book Value Per Share	-	-	81.45	72.17	63.92	57.81
Land	-	-	85.95	1.34	-	1.34
Buildings	-	-	69.45	65.41	-	50.27
Machinery	-	-	337.85	312.77	-	273.6

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error